Close

Nephron Starts Tandem Diabetes Care (TNDM) at Buy

July 12, 2022 3:22 PM EDT
Get Alerts TNDM Hot Sheet
Price: $35.56 +1.25%

Rating Summary:
    16 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE

Nephron analyst Chris Pasquale initiates coverage on Tandem Diabetes Care (NASDAQ: TNDM) with a Buy rating and a price target of $95.00.


For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.


Shares of Tandem Diabetes Care closed at $56.73 yesterday.


You May Also Be Interested In





Related Categories

New Coverage